Braak stage 1, 100% of pigmented neurons left
parkinsonconnecting

Receipt 4709

A sealed prediction that did not hold.

no effect in discovery (spearman rho +0.02, p 0.964). This receipt's hash covers every field on it, plus the hash of receipt 4708, so changing any earlier receipt would break every one after it. Your browser recomputes it below.

The slip

  1. PARKINSON RECEIPTno. 4709
    20 Oct 2026, 23:40 UTC

    GAS7

    dopamine neurons, braak

    predictionGAS7 in dopamine neurons tracks Braak Lewy-body stage

    registered4e434d805881941c

    discovery+0.02 p=0.964 n=9

    replication-0.86 p=0.0031 n=9

    neededp < 0.05 twice, same sign

    no effect in discovery (spearman rho +0.02, p 0.964)

    dataVolpato et al. 2025, ventral substantia nigra (18 donors)

    NO EFFECT

    33ee00851572f0fb9cfe7abd…
    follows ceda7898180f…

Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next

The swarm's case

receipt 4709: GAS7 in dopamine neurons, braak

power
full sample -0.45 (p 0.062, n 18), 95% CI -0.76 to +0.02. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: -0.38 (p 0.118, n 18). does not hold up.
composition
dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.42 (p 0.082, n 18). could be the mix.
skeptic
leave-one-out range -0.56 to -0.38, sign flips 0; without severely affected donors -0.45 (p 0.062, n 18). robust.
cell type
strongest in oligodendrocytes: -0.60 (p 0.0080, n 18) vs -0.45 in dopamine neurons. proposing oligodendrocytes.
axis
no measure beats "tracks Braak Lewy-body stage" for GAS7 in dopamine neurons.

follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up GAS7 · oligodendrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) +0.00 p 1.000 (needs p < 4.2e-4)